These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34878318)

  • 1. Clinical and Microbiological Characteristics of Recurrent Escherichia coli Bacteremia.
    Kobayashi T; Ikeda M; Okada Y; Higurashi Y; Okugawa S; Moriya K
    Microbiol Spectr; 2021 Dec; 9(3):e0139921. PubMed ID: 34878318
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Daga AP; Koga VL; Soncini JGM; de Matos CM; Perugini MRE; Pelisson M; Kobayashi RKT; Vespero EC
    Front Cell Infect Microbiol; 2019; 9():191. PubMed ID: 31245301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy.
    Williamson DA; Freeman JT; Porter S; Roberts S; Wiles S; Paterson DL; Johnson JR
    J Antimicrob Chemother; 2013 Dec; 68(12):2898-906. PubMed ID: 23833184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis.
    Bert F; Johnson JR; Ouattara B; Leflon-Guibout V; Johnston B; Marcon E; Valla D; Moreau R; Nicolas-Chanoine MH
    J Clin Microbiol; 2010 Aug; 48(8):2709-14. PubMed ID: 20519468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical features.
    Rodríguez-Baño J; Mingorance J; Fernández-Romero N; Serrano L; López-Cerero L; Pascual A;
    PLoS One; 2012; 7(9):e44238. PubMed ID: 22970186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of extended-spectrum β-lactamase/plasmid AmpC-β-lactamase-producing Escherichia coli isolates from long-term recurrent bloodstream infections.
    Roer L; Hansen F; Hasman H; Hammerum AM; Cavaco LM
    Int J Antimicrob Agents; 2020 Jul; 56(1):106041. PubMed ID: 32479890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremia.
    Mora-Rillo M; Fernández-Romero N; Navarro-San Francisco C; Díez-Sebastián J; Romero-Gómez MP; Fernández FA; López JRA; Mingorance J
    Virulence; 2015; 6(1):93-100. PubMed ID: 25654604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity.
    Burdet C; Clermont O; Bonacorsi S; Laouénan C; Bingen E; Aujard Y; Mentré F; Lefort A; Denamur E;
    Pediatr Infect Dis J; 2014 Aug; 33(8):872-9. PubMed ID: 25222308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.
    Rodríguez I; Figueiredo AS; Sousa M; Aracil-Gisbert S; Fernández-de-Bobadilla MD; Lanza VF; Rodríguez C; Zamora J; Loza E; Mingo P; Brooks CJ; Cantón R; Baquero F; Coque TM
    mSphere; 2021 Dec; 6(6):e0086821. PubMed ID: 34935444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomes of Escherichia coli bacteraemia isolates originating from urinary tract foci contain more virulence-associated genes than those from non-urinary foci and neutropaenic hosts.
    Dale AP; Pandey AK; Hesp RJ; Belogiannis K; Laver JR; Shone CC; Read RC
    J Infect; 2018 Dec; 77(6):534-543. PubMed ID: 30391630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection.
    Wang MC; Tseng CC; Chen CY; Wu JJ; Huang JJ
    Clin Infect Dis; 2002 Nov; 35(10):1161-6. PubMed ID: 12410475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda.
    Katongole P; Nalubega F; Florence NC; Asiimwe B; Andia I
    BMC Infect Dis; 2020 Jun; 20(1):453. PubMed ID: 32600258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli bacteraemia in patients with and without haematological malignancies: a study of strain characters and recurrent episodes.
    Olesen B; Kolmos HJ; Orskov F; Orskov I
    J Infect; 1998 Jan; 36(1):93-100. PubMed ID: 9515676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of Escherichia coli bacteremia in liver transplant recipients.
    Bert F; Huynh B; Dondero F; Johnson JR; Paugam-Burtz C; Durand F; Belghiti J; Valla D; Moreau R; Nicolas-Chanoine MH
    Transpl Infect Dis; 2011 Aug; 13(4):359-65. PubMed ID: 21355970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and microbiological characteristics of hospital- and community-onset Escherichia coli bloodstream infection.
    Chen X; Zou Q; Zhang W; Wang R; Yu F; Chen Y
    J Med Microbiol; 2019 Feb; 68(2):178-187. PubMed ID: 30624177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates.
    Cooke NM; Smith SG; Kelleher M; Rogers TR
    J Clin Microbiol; 2010 Apr; 48(4):1099-104. PubMed ID: 20107091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of virulence genes and clonality in Escherichia coli strains that cause bacteremia in cancer patients.
    Hilali F; Ruimy R; Saulnier P; Barnabé C; Lebouguénec C; Tibayrenc M; Andremont A
    Infect Immun; 2000 Jul; 68(7):3983-9. PubMed ID: 10858212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: Investigation of extra-intestinal pathogenic Escherichia coli virulence genes, bacterial motility, and multidrug resistance pattern of strains isolated from dairy cows with different severity scores of clinical mastitis.
    Guerra ST; Orsi H; Joaquim SF; Guimarães FF; Lopes BC; Dalanezi FM; Leite DS; Langoni H; Pantoja JCF; Rall VLM; Hernandes RT; Lucheis SB; Ribeiro MG
    J Dairy Sci; 2020 Apr; 103(4):3606-3614. PubMed ID: 32037173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients.
    Marschall J; Zhang L; Foxman B; Warren DK; Henderson JP;
    Clin Infect Dis; 2012 Jun; 54(12):1692-8. PubMed ID: 22431806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.